|
Industrial Profile
|
Industrial ProfileHOME>Industrial Profile
In 1999, Yatai Group prioritized the development of its newly found the pharmaceutical sector, which is composed of 17 companies including 4 new drug R&D institutes, 1 medical instrument R&D incubator, 7 pharmaceutical production enterprises, 3 pharmaceutical circulation enterprise, 1 Changbai Mountain rare medicine and food development company and 1 pharmaceutical industrial park management enterprise, Currently a healthy industry chain integrating pharmaceutical R&D, production, circulation, medical service, park management and development and extraction of rare herbal and medicinal resources under the Rare Forest in Changbai Mountain has been completed. Yatai pharmaceutical industry also possesses four First Class National New Drugs: Ginsenoside Rg3 injection, H5N1 Human Bird Flu Vaccine, Vicagrel Platelet Aggregation Inhibitors, Forsythin Antiviral and Antipyretic New Drug. The total assets of Yatai Group’s medical and pharmaceutical sector by the end of 2016 reached 5 billion Yuan.
Among them, Yatai International Pharmaceutical & and Health Industrial Park, with an area of 680,000 m2 located in an advantageous newly developed section of Changchun, has been selected as the key project of Jilin Industrial Transformation Update. It serves as a base for the production of Pharmaceutical health products and medicine, R&D of medical equipment, and large-scale Market circulation complete with intelligent manufacturing, international product innovation and incubation, large-scale market circulation of big health products, becoming a highly competitive international pharmaceutical industrial park located in Northeastern China.
|
